Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Featured 3
Featured 3
Featured posts
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
‘Never Too Late’: Tobacco Cessation Programs Benefit Patients With Cancer
Oncology Trials Could Benefit From Increased Data on Tobacco Use
IASLC 2020 World Conference on Lung Cancer Postponed
IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...
lungcanc
The IASLC’s Spotlight on Screening
lungcanc
1
2
Page 2 of 2
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
